Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Reproductive BioMedicine OnlineReferences
- Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.Hum. Reprod. Update. 2003; 9: 275-289
- Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.J. Clin. Endocrinol. Metab. 2007; 92: 2931-2937
- Regulation of vascular permeability by vascular endothelial growth factors.Vascul. Pharmacol. 2002; 39: 225-237
- The effect of VEGF on the temporal-spatial change of alpha-tubulin and cortical granules of ovine oocytes matured in vitro.Anim. Reprod. Sci. 2009; 113: 236-250
- Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study.Reprod. Biomed. Online. 2008; 17: 751-755
- Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.Hum. Reprod. Update. 2002; 8: 559-577
- Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility.Fertil. Steril. 2008; 90: 2340-2350
- Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.J. Biol. Chem. 2001; 276: 3222-3230
- Ovarian hyperstimulation syndrome: an update review.Obstet. Gynecol. Surv. 1989; 44: 430-440
- Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.Biol. Reprod. 2003; 68: 2164-2171
- Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.Endocrinology. 2006; 147: 5400-5411
- IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial.Hum. Reprod. 2005; 20: 1261-1265
- Trials to assess equivalence: the importance of rigorous methods.BMJ. 1996; 313: 36-39
- Role of vascular endothelial growth factor in ovarian physiology – an overview.Reprod. Biol. 2005; 5: 111-136
- The pathogenesis of the ovarian hyperstimulation syndrome.N. Engl. J. Med. 2003; 349: 729-732
- Coasting – what is the best formula?.Hum. Reprod. 2003; 18: 937-940
- Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline.Stat. Med. 1999; 18: 1903-1942
- Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.J. Assist. Reprod. Genet. 2007; 24: 331-336
- Effect of vascular endothelial growth factor on maturation, fertilization and developmental competence of bovine oocytes.J. Vet. Med. Sci. 2002; 64: 803-806
- Can we eliminate severe ovarian hyperstimulation syndrome? Comment I.Hum. Reprod. 2005; 20 (author reply 2369–2370): 2368-2369
- Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?.Eur. J. Obstet. Gynecol. Reprod. Biol. 2005; 122: 127-128
- Distinction between early and late ovarian hyperstimulation syndrome.Fertil. Steril. 2000; 73: 901-907
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.Lancet. 1994; 344: 235-236
- Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.Fertil. Steril. 2006; 85: 112-120
- Etiology of OHSS and use of dopamine agonists.Fertil. Steril. 2012; 97: 517-522
- Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.Hum. Reprod. Update. 2008; 14: 321-333
- Cabergoline for preventing ovarian hyperstimulation syndrome.Cochrane Database Syst. Rev. 2012; 2: CD008605
- High fertilization and implantation rates after intracytoplasmic sperm injection.Hum. Reprod. 1993; 8: 1061-1066
- Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.J. Clin. Endocrinol. Metab. 2002; 87: 3300-3308
- Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development.J. Clin. Invest. 2003; 112: 659-669
Article info
Publication history
Footnotes
Kok-Min Seow received his MD degree from the National Yang-Ming University, Taiwan in 1996. After completing residency training at the Shin-Kong Wu Ho-Su Memorial Hospital, he served as an attending physician at the Shin-Kong Wu Ho-Su Memorial Hospital. In 2007, he obtained his PhD degree from the department of clinical medicine, National Yang-Ming University. He is also an assistant professor at the school of medicine, National Yang-Ming University. His clinical interests include prenatal ultrasound diagnosis and laparoscopic surgery and his research interest is insulin resistance in polycystic ovary syndrome.